tiprankstipranks
Takeda Pharmaceutical Co Ltd (JP:4502)
:4502
Japanese Market
4502
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4502 full AI Analyst Report?

Takeda Pharmaceutical Co (4502) Financial Statements

8 Followers

Takeda Pharmaceutical Co Financial Overview

Takeda Pharmaceutical Co's market cap is currently ¥8.33T. The company's EPS TTM is ¥121.97; its P/E ratio is 46.52; and it has a dividend yield of 4.11%. Takeda Pharmaceutical Co is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is ¥60.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 4.51T¥ 4.58T¥ 4.26T¥ 4.03T¥ 3.57T
Gross Profit¥ 2.30T¥ 2.46T¥ 2.32T¥ 2.30T¥ 2.04T
Operating Income¥ 540.45B¥ 627.54B¥ 531.42B¥ 658.29B¥ 610.50B
EBITDA¥ 1.26T¥ 1.13T¥ 927.95B¥ 1.18T¥ 1.04T
Net Income¥ 191.76B¥ 107.93B¥ 144.07B¥ 317.02B¥ 230.06B
Balance Sheet
Cash & Short-Term Investments¥ 595.05B¥ 385.11B¥ 457.80B¥ 533.53B¥ 849.70B
Total Assets¥ 15.45T¥ 14.25T¥ 15.11T¥ 13.96T¥ 13.18T
Total Debt¥ 4.88T¥ 5.09T¥ 5.46T¥ 4.86T¥ 4.81T
Net Debt¥ 4.29T¥ 4.85T¥ 5.26T¥ 4.63T¥ 3.96T
Total Liabilities¥ 7.68T¥ 7.31T¥ 7.83T¥ 7.60T¥ 7.49T
Stockholders' Equity¥ 7.77T¥ 6.94T¥ 7.27T¥ 6.35T¥ 5.68T
Cash Flow
Free Cash Flow¥ 762.71B¥ 761.70B¥ 464.90B¥ 736.56B¥ 897.97B
Operating Cash Flow¥ 938.71B¥ 962.49B¥ 640.32B¥ 877.22B¥ 1.02T
Investing Cash Flow¥ -387.80B¥ -385.36B¥ -488.21B¥ -615.72B¥ -204.44B
Financing Cash Flow¥ -375.44B¥ -638.44B¥ -254.04B¥ -600.59B¥ -962.06B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History

Income Statement >

Takeda Pharmaceutical Co Debt to Assets

Balance Sheet >

Takeda Pharmaceutical Co Cash Flow

Cash Flow >

Takeda Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >